Scripts were reported for Ranexa today that showed 25% gains from the prior week and a new record on all fronts of renewals and total scripts written for the week of December 5th, 2008

This link will show a record of scripts for Ranexa since launch as well as the stock price in comparison to the surge in prescriptions for this now "front line" defense against angina:

Click Here

Quite interesting to see the build in this drugs script base as it now greatly expands it's label usage against a wider audience and as Europe starts ramping up as well.

The April $10 calls I reccomended 12 days ago at $1.50 are now bid $1.20 to $1.50. The open interest is only 435 contracts, although I expect that to grow dramatically as we move into 2009.

As soon as the December options series expires Friday I will start looking at the February series of options as they start and if I can get the Feb $10 calls for under $.50 I may take a shot there as I wouldn't be surprised to see a move to $14 or so at some point.

Again, I traded CVTX before, many years ago and I have seen this stock pop/gap bigtime, while I was in it, as it lulled everyone to sleep thinking it was controlled by market makers.

Nothing can take the place of panic short covering, good news and Investment bank upgrades... Especially when you are long stock and options.

Gotta be in em' to win em'